Ventolin HFA Sales Data
| Rank 95 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Ventolin HFA U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 95 ( ) |
$183,060 | n/a | 5,505 | n/a |
| Q2 2013 | 97 ( 12) |
$174,225 | -11.76% | 5,363 | -11.55% |
| Q1 2013 | 85 ( 5) |
$197,453 | 6.00% | 6,063 | 1.27% |
| Q4 2012 | 90 () |
$186,276 | n/a | 5,987 | n/a |
| Q2 2012 | 99 (3) |
$160,832 | -6.88% | 5,215 | -8.57% |
| Q1 2012 | 96 () |
$172,707 | n/a | 5,704 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
